Medications for Immunosuppression
What is Immunosuppression: Immunosuppression is a disorder or condition where the immune response is reduced or absent.
Medications to treat Immunosuppression
The following list of medications are in some way related to, or used in the treatment of this condition.
| Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| prednisone | Rx | C | N | 3 reviews | |||
|
Generic name: prednisone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
| prednisolone | Rx | C | N | 1 review | |||
|
Generic name: prednisolone systemic Brand names: Prelone, Veripred 20, Millipred, PediaPred, Millipred DP, Orapred ODT … Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
| methylprednisolone | Rx | C | N | 4 reviews | |||
|
Generic name: methylprednisolone systemic Brand names: MethylPREDNISolone Dose Pack, Medrol, Depo-Medrol, Solu-Medrol, Medrol Dosepak … Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
| MethylPREDNISolone Dose Pack | Rx | C | N | 2 reviews | |||
|
Generic name: methylprednisolone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects |
|||||||
| Medrol | Rx | C | N | Add review | Add | ||
|
Generic name: methylprednisolone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
| Depo-Medrol | Rx | C | N | Add review | Add | ||
|
Generic name: methylprednisolone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
| Solu-Medrol | Rx | C | N | Add review | Add | ||
|
Generic name: methylprednisolone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
| Prelone | Rx | C | N | Add review | Add | ||
|
Generic name: prednisolone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects |
|||||||
| Medrol Dosepak | Rx | C | N | Add review | Add | ||
|
Generic name: methylprednisolone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects |
|||||||
| Veripred 20 | Rx | C | N | Add review | Add | ||
|
Generic name: prednisolone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
| Millipred | Rx | C | N | Add review | Add | ||
|
Generic name: prednisolone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
| PediaPred | Rx | C | N | Add review | Add | ||
|
Generic name: prednisolone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
| Millipred DP | Rx | C | N | Add review | Add | ||
|
Generic name: prednisolone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects |
|||||||
| Orapred ODT | Rx | C | N | Add review | Add | ||
|
Generic name: prednisolone systemic Drug class: glucocorticoids For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Legend
| Off Label | This medication may not be approved by the FDA for the treatment of this condition. |
| Prescription Only / Over the Counter | |
|---|---|
| Rx | Prescription Only |
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Pregnancy | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
| N | FDA has not classified the drug. |
| Controlled Substances Act Schedule | |
|---|---|
| N | Is not subject to the Controlled Substances Act. |
| 1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
| 2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
| 3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
| 5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |